SURVEY: 1/3 OF GLP-1 USERS ARE LOWER-INCOME
A BTIG survey of 1,000 U.S. GLP-1 users found one-third earn under $45k, despite drug costs of $500–$1,000/month. Analysts cite cheaper compound versions (~$130) and Medicaid coverage as expanding access.The drugs are reshaping eating habits: 70% dine out less, with sharp cutbacks in soda (68%), pizza (67%), alcohol (63%), and snacks (58%). Users report cutting 300–800 calories/day, pressuring restaurants.BTIG estimates 5–10% of U.S. adults now use GLP-1s, with growth expected. Restaurants, especially fast food and pizza chains, could face a 120–230 bps sales hit, though healthier concepts like Chipotle and Sweetgreen may fare better.The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments